Classification of the Four Main Types of Lung Cancer Using a MicroRNA-Based Diagnostic Assay
Authors:
- Gila Lithwick-YanaiGLGila Lithwick-Yanai
- Iris BarshackIBIris Barshack
- Sima BenjaminSBSima Benjamin
- Irit KrivitskyIKIrit Krivitsky
- Tina Bocker EdmonstonTETina Bocker Edmonston
- Marluce BibboMBMarluce Bibbo
- Craig ThurmCTCraig Thurm
- Laurie HorowitzLHLaurie Horowitz
- Yajue HuangYHYajue Huang
- Meora FeinmesserMFMeora Feinmesser
- J. Steve HouJHJ. Steve Hou
- 1 September 2012
- journal article
- research article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 14 (5) , 510-517
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Proteomic analysis of formalin-fixed, paraffin-embedded lung neuroendocrine tumor samples from hospital archivesJournal of Proteomics, 2011
- Cytologic diagnosis and differential diagnosis of lung carcinoid tumors a retrospective study of 63 cases with histologic correlationCancer Cytopathology, 2010
- Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine‐needle aspiration specimensDiagnostic Cytopathology, 2009
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Phase II Study of Efficacy and Safety of Bevacizumab in Combination With Chemotherapy or Erlotinib Compared With Chemotherapy Alone for Treatment of Recurrent or Refractory Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- Bevacizumab in Non–Small Cell Lung CancerClinical Cancer Research, 2007
- Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21Clinical Lung Cancer, 2006
- Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control studyLung Cancer, 2006
- Lung Cancer Histologic Type in the Surveillance, Epidemiology, and End Results Registry Versus Independent ReviewJNCI: Journal of the National Cancer Institute, 2004
- Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2004